Legal & General Group
CLVS

Legal & General Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-559
Closed -$1K 3451
2022
Q3
$1K Sell
559
-27,431
-98% -$49.1K ﹤0.01% 3453
2022
Q2
$50K Sell
27,990
-36,734
-57% -$65.6K ﹤0.01% 3004
2022
Q1
$131K Buy
64,724
+410
+0.6% +$830 ﹤0.01% 2803
2021
Q4
$174K Buy
64,314
+4,126
+7% +$11.2K ﹤0.01% 2769
2021
Q3
$268K Buy
60,188
+20,949
+53% +$93.3K ﹤0.01% 2595
2021
Q2
$228K Buy
39,239
+24,518
+167% +$142K ﹤0.01% 2504
2021
Q1
$103K Buy
14,721
+214
+1% +$1.5K ﹤0.01% 2613
2020
Q4
$70K Hold
14,507
﹤0.01% 2698
2020
Q3
$85K Sell
14,507
-1,976
-12% -$11.6K ﹤0.01% 2534
2020
Q2
$111K Buy
16,483
+6,576
+66% +$44.3K ﹤0.01% 2499
2020
Q1
$63K Sell
9,907
-13,642
-58% -$86.8K ﹤0.01% 2531
2019
Q4
$246K Buy
23,549
+125
+0.5% +$1.31K ﹤0.01% 2349
2019
Q3
$92K Buy
23,424
+1,577
+7% +$6.19K ﹤0.01% 2550
2019
Q2
$324K Buy
21,847
+1,192
+6% +$17.7K ﹤0.01% 2233
2019
Q1
$513K Buy
20,655
+198
+1% +$4.92K ﹤0.01% 2150
2018
Q4
$368K Buy
20,457
+4,711
+30% +$84.7K ﹤0.01% 2185
2018
Q3
$463K Hold
15,746
﹤0.01% 2158
2018
Q2
$716K Sell
15,746
-451
-3% -$20.5K ﹤0.01% 2026
2018
Q1
$855K Sell
16,197
-3,115
-16% -$164K ﹤0.01% 1951
2017
Q4
$1.31M Buy
19,312
+1,350
+8% +$91.8K ﹤0.01% 1788
2017
Q3
$1.48M Buy
17,962
+2,269
+14% +$186K ﹤0.01% 1718
2017
Q2
$1.46M Buy
15,693
+3,090
+25% +$288K ﹤0.01% 1686
2017
Q1
$798K Buy
12,603
+1,087
+9% +$68.8K ﹤0.01% 1879
2016
Q4
$510K Buy
11,516
+3,285
+40% +$145K ﹤0.01% 1976
2016
Q3
$288K Sell
8,231
-252
-3% -$8.82K ﹤0.01% 1935
2016
Q2
$118K Hold
8,483
﹤0.01% 2008
2016
Q1
$164K Buy
8,483
+3,072
+57% +$59.4K ﹤0.01% 1799
2015
Q4
$186K Buy
5,411
+256
+5% +$8.8K ﹤0.01% 1774
2015
Q3
$477K Buy
5,155
+545
+12% +$50.4K ﹤0.01% 1311
2015
Q2
$397K Hold
4,610
﹤0.01% 1396
2015
Q1
$347K Buy
4,610
+923
+25% +$69.5K ﹤0.01% 1412
2014
Q4
$209K Sell
3,687
-87
-2% -$4.93K ﹤0.01% 1548
2014
Q3
$178K Buy
+3,774
New +$178K ﹤0.01% 1570